tetraethylammonium has been researched along with Lymphoma, B-Cell in 2 studies
Tetraethylammonium: A potassium-selective ion channel blocker. (From J Gen Phys 1994;104(1):173-90)
Lymphoma, B-Cell: A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, ZH | 1 |
| Unlap, T | 1 |
| Li, L | 1 |
| Ma, HP | 2 |
| Wang, J | 1 |
| Xu, YQ | 1 |
| Liang, YY | 1 |
| Gongora, R | 1 |
| Warnock, DG | 1 |
2 other studies available for tetraethylammonium and Lymphoma, B-Cell
| Article | Year |
|---|---|
Incomplete inactivation of voltage-dependent K+ channels in human B lymphoma cells.
Topics: Electric Conductivity; Electrophysiology; Humans; Lymphoma, B-Cell; Membrane Potentials; Oligonucleo | 2002 |
An intermediate-conductance Ca(2+)-activated K (+) channel mediates B lymphoma cell cycle progression induced by serum.
Topics: Antigens, CD20; Calcium; Cell Cycle; Cell Line, Tumor; Chromones; Enzyme Inhibitors; Flow Cytometry; | 2007 |